Michael E. Tarnoff's most recent trade in Angiodynamic Inc was a trade of 20,541 Common Stock done . Disclosure was reported to the exchange on July 17, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 65,703 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 7,060 | 28,121 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 5,738 | 21,061 (0%) | 0% | 0 | Common Stock |